Lilly’s Alzheimer’s super drug to be approved ‘any day’

MELBOURNE: The pharma giant behind breakthrough Alzheimer’s drug Donanemab expects approval to come from US

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In